Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
73M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
49.7M
-
Shares change
-
+7.2M
-
Total reported value, excl. options
-
$1.67B
-
Value change
-
+$244M
-
Put/Call ratio
-
0.45
-
Number of buys
-
84
-
Number of sells
-
-58
-
Price
-
$33.50
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q1 2023
166 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.7M shares
of 73M outstanding shares and own 68.11% of the company stock.
Largest 10 shareholders include FMR LLC (7.6M shares), CITADEL ADVISORS LLC (3.01M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.69M shares), Capital International Investors (2.38M shares), venBio Partners LLC (2.3M shares), BlackRock Inc. (2.05M shares), Avidity Partners Management LP (1.92M shares), VANGUARD GROUP INC (1.81M shares), JANUS HENDERSON GROUP PLC (1.6M shares), and RTW INVESTMENTS, LP (1.39M shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.